Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Catherine Belle Meador, M.D.

Concepts (124)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Small Cell Lung Carcinoma820254541.540 Why?
Lung Neoplasms212025135941.380 Why?
Drug Resistance, Neoplasm11202453420.920 Why?
Thoracic Neoplasms120232690.700 Why?
Carcinoma, Non-Small-Cell Lung5202354340.680 Why?
Central Nervous System1202513460.570 Why?
Leadership2201613960.540 Why?
Piperazines2202525530.520 Why?
Molecular Targeted Therapy3202028300.490 Why?
Genotype32021130480.490 Why?
Protein Kinase Inhibitors6202157070.490 Why?
Antineoplastic Agents62021136980.440 Why?
Mutation122024302660.350 Why?
Biomedical Research2201634630.350 Why?
MAP Kinase Signaling System2201514950.310 Why?
Proto-Oncogene Proteins B-raf2201520590.300 Why?
Antineoplastic Combined Chemotherapy Protocols42025118860.290 Why?
Acrylamides320172610.240 Why?
Neoplasms42023223890.240 Why?
Negotiating220161520.230 Why?
Education, Medical, Graduate1201624220.220 Why?
Education, Medical1201617420.220 Why?
Exodeoxyribonucleases120241910.210 Why?
Phthalazines120253970.200 Why?
Epigenomics220249610.190 Why?
Aniline Compounds3201710950.180 Why?
Career Choice220167690.170 Why?
Biology120212920.160 Why?
Paraneoplastic Syndromes, Nervous System12019240.160 Why?
Gene Amplification1202410990.160 Why?
Genetic Variation1201466110.160 Why?
Quinazolines2201513730.150 Why?
Tumor Microenvironment3202439520.150 Why?
Cardiology Service, Hospital120192420.150 Why?
Mice, Nude4201736310.140 Why?
Focal Adhesion Protein-Tyrosine Kinases120171850.130 Why?
Receptor, EphA212016410.130 Why?
Phosphoproteins1202424520.120 Why?
Exons1202123950.120 Why?
Humans2720257689700.120 Why?
Colorectal Neoplasms1201569820.120 Why?
Group Processes120162280.120 Why?
src-Family Kinases120175390.120 Why?
Neoplasm Recurrence, Local3202594420.110 Why?
Cell Line, Tumor72024171730.110 Why?
Niacinamide120164180.110 Why?
Lymphocytes, Tumor-Infiltrating1201911050.110 Why?
Professional Competence120164300.100 Why?
Curriculum2201637820.100 Why?
INDEL Mutation120132670.100 Why?
Patient Admission1201913700.100 Why?
Cell Lineage1202025760.090 Why?
Cell Transformation, Neoplastic2202428480.090 Why?
Benzamides1201613870.090 Why?
DNA, Neoplasm1201517480.080 Why?
Xenograft Model Antitumor Assays3202436210.080 Why?
Animals1120241693350.080 Why?
Academic Medical Centers1201927840.080 Why?
Treatment Outcome42025654800.080 Why?
Receptor Protein-Tyrosine Kinases1201416290.070 Why?
Protein-Tyrosine Kinases1201524330.070 Why?
Sensitivity and Specificity12021147520.060 Why?
Genome, Human2201544560.060 Why?
Octamer Transcription Factors12023180.060 Why?
Healthcare Disparities1201934210.060 Why?
Aged, 80 and over32025597390.050 Why?
Mice82024820720.050 Why?
Biopsy1201568050.050 Why?
Lactates120234010.050 Why?
Cell Proliferation22016104860.050 Why?
Health Services Accessibility1201955220.050 Why?
Aged520251717860.050 Why?
Genetic Testing1201435910.040 Why?
Chemokines120249630.040 Why?
Proto-Oncogene Proteins c-myc120249980.040 Why?
Male620253652030.040 Why?
Genomics1201459280.040 Why?
Adenocarcinoma1201564010.040 Why?
Gene Expression Regulation, Neoplastic2202486640.040 Why?
Basic Helix-Loop-Helix Transcription Factors1202311430.040 Why?
Pneumonectomy1202311590.030 Why?
Middle Aged420252237370.030 Why?
Melanoma1201457090.030 Why?
Heart Failure12019118790.030 Why?
Female620253975150.030 Why?
Chemotherapy, Adjuvant1202335540.030 Why?
Survival Rate22019128730.030 Why?
Drug Screening Assays, Antitumor120157190.030 Why?
Immunity, Innate1202430800.020 Why?
Adult220252238510.020 Why?
Drug Synergism1201617620.020 Why?
Combined Modality Therapy1202385590.020 Why?
Epigenesis, Genetic1202438360.020 Why?
Drug Evaluation, Preclinical1201513400.020 Why?
CD8-Positive T-Lymphocytes1202446510.020 Why?
DNA Methylation1202444320.020 Why?
ras Proteins1201510580.020 Why?
Benzimidazoles120158640.020 Why?
Transfection1201757630.020 Why?
Signal Transduction32017236530.020 Why?
Neoplasm Staging12023112620.020 Why?
Macrophages1202358010.020 Why?
Immunotherapy1202447560.020 Why?
Inpatients1201925690.020 Why?
Health Status Disparities1201918860.020 Why?
Retrospective Studies32023819030.020 Why?
Proto-Oncogene Proteins p21(ras)1201517690.020 Why?
Boston1201993770.020 Why?
Drug Therapy, Combination1201563200.020 Why?
Patient Readmission1201933130.020 Why?
Lung12023100990.010 Why?
DNA Copy Number Variations1201320550.010 Why?
Transcription Factors12023121740.010 Why?
Sequence Analysis, DNA1201347850.010 Why?
Longitudinal Studies12017147940.010 Why?
High-Throughput Nucleotide Sequencing1201336710.010 Why?
Apoptosis1201695270.010 Why?
Prognosis12019300460.010 Why?
Risk Assessment12019243330.010 Why?
Time Factors12019402610.010 Why?
Follow-Up Studies12017393940.010 Why?
Polymorphism, Single Nucleotide12013160530.010 Why?
Prospective Studies12017549620.010 Why?
Risk Factors12019749760.010 Why?
Meador's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (124)
Explore
_
Co-Authors (112)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.